Back to Authors

Moore, Phillip

https://orcid.org/0000-0002-7012-1145

Mayo Clinic

University of California, San Francisco

Citations 3

Novel delivery technique for atrial septal defect closure in young children utilizing the GORE® CARDIOFORM® septal occluder
Anderson, Jason H. , Fraint, Hannah, Moore, Phillip , Taggart, Nathaniel W. , Cabalka, Allison K. , Taggart, Nathaniel W , Anderson, Jason

Catheterization and Cardiovascular Interventions | November 29, 2016 | Volume: 89 | Issue: 7 | Pages: 1232-1238

10.1002/ccd.26874 Get It

ObjectivesTo develop a novel delivery technique to overcome vascular size limitations for device closure of a secundum ASD in the young patient.BackgroundThe efficacy, clinical utility, and safety of transcatheter closure in comparison to surgical closure are well established; however, access vessel size remains a potential limitation to device selection in the young patient.MethodsA retrospective medical record review of all cases of secundum ASD closure between April 2015 and April 2016 utilizing a novel delivery method described herein at two separate academic institutions. The device is disassembled allowing the delivery sheath to serve as the introducer. It is advanced to the RA with re‐introduction of the device allowing for deployment in the standard fashion.ResultsOverall, 10 patients underwent secundum ASD closure via this novel delivery technique. There were six females (60%) and the average age at time of the procedure was 4.2 years ± 1.6 years (range 2–6 years). The majority of patients had an isolated secundum ASD (70%) with the primary indication for closure being right ventricular volume overload (90%). All patients had successful placement of a GORE® CARDIOFORM® Septal Occluder (GCSO) with no or trivial residual shunt. No patients had vascular complications related to the procedure.ConclusionsWe describe a novel technique for ASD closure using the GCSO delivery sheath as the access sheath, which reduces the vascular access size requirement by 25%, thus addressing one common limitation for percutaneous device closure of a secundum ASD in young patients. © 2016 Wiley Periodicals, Inc.
CRISP: Catheterization RISk score for pediatrics: A Report from the Congenital Cardiac Interventional Study Consortium (CCISC)
Nykanen, David, Forbes, Thomas J., Du, Wei , Divekar, Abhay , Reeves, Jaxk, Hagler, Donald J. , Fagan, Thomas E. , Pedra, Carlos A. C., Fleming, Gregory A. , Khan, Danyal , Javois, Alexander J., Gruenstein, Daniel H., Qureshi, Shakeel A. , Moore, Phillip, Wax, David H., Moore, Phillip , Wax, David

Catheterization and Cardiovascular Interventions | November 3, 2015 | Volume: 87 | Issue: 2 | Pages: 302-309

10.1002/ccd.26300 Get It

ObjectivesWe sought to develop a scoring system that predicts the risk of serious adverse events (SAE's) for individual pediatric patients undergoing cardiac catheterization procedures.BackgroundSystematic assessment of risk of SAE in pediatric catheterization can be challenging in view of a wide variation in procedure and patient complexity as well as rapidly evolving technology.MethodsA 10 component scoring system was originally developed based on expert consensus and review of the existing literature. Data from an international multi‐institutional catheterization registry (CCISC) between 2008 and 2013 were used to validate this scoring system. In addition we used multivariate methods to further refine the original risk score to improve its predictive power of SAE's. Results: Univariate analysis confirmed the strong correlation of each of the 10 components of the original risk score with SAE attributed to a pediatric cardiac catheterization (P < 0.001 for all variables). Multivariate analysis resulted in a modified risk score (CRISP) that corresponds to an increase in value of area under a receiver operating characteristic curve (AUC) from 0.715 to 0.741.ConclusionThe CRISP score predicts risk of occurrence of an SAE for individual patients undergoing pediatric cardiac catheterization procedures. © 2015 Wiley Periodicals, Inc.
SCAI expert consensus statement for advanced training programs in pediatric and congenital interventional cardiac catheterization
Armsby, Laurie B., Beekman, Robert H., Fagan, Thomas E. , Hagler, Donald J. , Hijazi, Ziyad M. , Holzer, Ralf J. , Ing, Frank F. , Kreutzer, Jacqueline , Levi, Daniel S. , Moore, Phillip, Mullins, Charles E., Ruíz, Carlos , Vincent, Robert, Benson, Lee N. , LANG, PETER J. , Latson, Larry , Moore, Phillip

Catheterization and Cardiovascular Interventions | May 29, 2014 | Volume: 84 | Issue: 5 | Pages: 779-784

10.1002/ccd.25550 Get It

Pediatric and Congenital Interventional Cardiology is the practice of catheter‐based techniques that improve cardiac physiology and circulation through the treatment of heart disease in children and adults with congenital or acquired heart defects. Over the last decade, and since last published training guidelines for pediatric cardiac catheterization and interventional cardiology were published in 2005 [1] the field of Pediatric and Congenital Cardiac Catheterization has evolved into a predominantly interventional discipline. As there is no sub‐specialty certification for interventional cardiac catheterization in pediatrics, the Congenital Heart Disease Committee of the Society of Cardiovascular Angiography and Interventions has put together this consensus statement for advanced training in pediatric and congenital interventional cardiac catheterization. The statement puts forth recommendations for program infrastructure in terms of teaching, personnel, equipment, facilities, conferences, patient volume and trainee assessment. This is meant to set a standard for training programs as well as giving applicants a basis on which to judge and compare programs. © 2014 Wiley Periodicals, Inc.